Photo of Charley Budgeon

View Scopus Profile

Charley Budgeon

Dr, BSc W.Aust.

  • The University of Western Australia (M019), 35 Stirling Highway,

    6009 Perth

    Australia

  • 696 Citations
  • 13 h-Index
20122019
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Applied statistics
  • Biometrics
  • Medical statistics
  • Epidemiology
  • Statistical model/variable selection
  • Big data
  • Statistical consulting

Fingerprint Dive into the research topics where Charley Budgeon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Indwelling Catheters Medicine & Life Sciences
Colchicine Medicine & Life Sciences
Secondary Prevention Medicine & Life Sciences
Stroke Medicine & Life Sciences
Merkel cell polyomavirus Medicine & Life Sciences
Palatal Expansion Technique Medicine & Life Sciences
Pleurodesis Medicine & Life Sciences
Merkel Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

Changes in pulp blood flow and pulp sensibility resulting from surgically assisted rapid maxillary expansion: A clinical study

Naoum, S., Goonewardene, M., Abbott, P. V., Karunanayake, K. & Budgeon, C., 1 May 2019, In : American Journal of Orthodontics and Dentofacial Orthopedics. 155, 5, p. 632-641 10 p.

Research output: Contribution to journal › Article

Palatal Expansion Technique
Carbon Monoxide
Orthopedics
Tooth
Clinical Studies
1 Citation (Scopus)

Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases

Fitzgerald, D. B., Leong, S. L., Budgeon, C. A., Murray, K., Rosenstengal, A., Smith, N. A., Bielsa, S., Clive, A. O., Maskell, N. A., Porcel, J. M. & Lee, Y. C. G., Jan 2019, In : Journal of Thoracic Disease. 11, 1, p. 123-130 8 p.

Research output: Contribution to journal › Article

Open Access

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics

LoDoCo2 Investigators, 1 Dec 2019, In : American Heart Journal. 218, p. 46-56 11 p.

Research output: Contribution to journal › Article

Colchicine
Coronary Artery Disease
Secondary Prevention
Cardiovascular Diseases
Safety
17 Citations (Scopus)

Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial

Muruganandan, S., Azzopardi, M., Fitzgerald, D. B., Shrestha, R., Kwan, B. C. H., Lam, D. C. L., De Chaneet, C. C., Ali, M. R. S. R., Yap, E., Tobin, C. L., Garske, L. A., Nguyen, P. T., Stanley, C., Popowicz, N. D., Kosky, C., Thomas, R., Read, C. A., Budgeon, C. A., Feller-Kopman, D., Maskell, N. A. & 2 othersMurray, K. & Lee, Y. C. G., Sep 2018, In : Lancet Respiratory Medicine. 6, 9, p. 671-680 10 p.

Research output: Contribution to journal › Article

Association between adherence to azithromycin and dornase alpha and lung function decline in adult cystic fibrosis (CF) patients: a two-year analysis

Popowicz, N., Wood, J., Mulrennan, S., Budgeon, C. & Ryan, G., Jun 2018, p. S127.

Research output: Contribution to conference › Poster

Azithromycin
Cystic Fibrosis
Anti-Bacterial Agents
Lung
Medication Adherence